Study of Telintra for Treatment of Chemotherapy Induced Neutropenia in Patients With Non-Small Cell Lung Cancer
Public ClinicalTrials.gov record NCT00701870. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 2 Randomized Study of Ezatiostat Hydrochloride (Telintra™, TLK199 Tablets) for Treatment of Chemotherapy Induced Neutropenia in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Receiving First-Line Chemotherapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
TLK199.2102 was a multicenter Phase 2 randomized study to determine the effect of Telintra treatment on chemotherapy induced neutropenia (CIN) in patients with non small cell lung cancer receiving first-line therapy with carboplatin and docetaxel.
Study identification
- NCT ID
- NCT00701870
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 1 participant
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2008 (Type not available)
- Primary completion
- Nov 2008 (Actual)
- Completion
- Nov 2008 (Actual)
- Last update posted
- Nov 27, 2013
2008
United States locations
- U.S. sites
- 24
- U.S. states
- 9
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Central Hematology Oncology Medical Group | Alhambra | California | 91801 | — |
| Pacific Cancer Medical Center, Inc. | Anaheim | California | 92801 | — |
| Providence St. Joseph Medical Center | Burbank | California | 91505 | — |
| St. Jude Heritage Healthcare | Fullerton | California | 92835 | — |
| Wilshire Oncology Medical Group | La Verne | California | 91750 | — |
| UCLA Medical Center | Los Angeles | California | 90095 | — |
| Clinical Trials and Research Associates, Inc. | Montebello | California | 90640 | — |
| North Valley Hematology/Oncology Medical Group | Northridge | California | 91325 | — |
| Ventura County Hematology-Oncology Specialists | Oxnard | California | 93030 | — |
| Samsum Clinic | Santa Barbara | California | 93105 | — |
| Santa Barbara Hematology Oncology Medical Group, Inc. | Santa Barbara | California | 93105 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| Broward Oncology Associates | Fort Lauderdale | Florida | 33308 | — |
| Nature Coast Clinical Research | Inverness | Florida | 34452 | — |
| Lakeland Regional Cancer Center | Lakeland | Florida | 33805 | — |
| Florida Hospital Cancer Institute | Ormand Beach | Florida | 32174 | — |
| Suburban Hematology-Oncology Associates, PC | Lawrenceville | Georgia | 30045 | — |
| Medical & Surgical Specialists | Galesburg | Illinois | 61401 | — |
| Joliet Oncology/Hematology Associates, Ltd. | Joliet | Illinois | 60435 | — |
| Comprehensive Cancer Centers of Nevada | Henderson | Nevada | 89052 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| Case Medical Center-University Hospitals | Cleveland | Ohio | 44106 | — |
| The University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | — |
| Coastal Cancer Center | Myrtle Beach | South Carolina | 29572-4128 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00701870, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2013 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00701870 live on ClinicalTrials.gov.